One of my NP’s presented a new consult to me this week: 15cm central HCC, wheelchair bound, heart and renal failure, blistering wounds on the legs from severe edema requiring daily dressing changes and whirlpool therapy for debridement...you get the picture. She advised me not to treat him.
The IO Central Chemoembolization Discussion Group this week raised the issue of getting insurance approval for atypical tumors. Not surprisingly, the insurer in this case turned out to be Blue Cross, one of the worst carriers for Interventional Oncology procedures.
